BRIEF-Abbott Receives FDA Approval For New Cardiomems Hf System Capabilities That Help Patients Engage In The Care Of Their Heart Condition
Reuters2026/10/05 13:12Abbott Laboratories ABT.N: ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION ABBOTT - CARDIOGUIDE HF APP AND DYNAMIC TREATMENT PLAN TO BE AVAILABLE LATER THIS YEAR Source text: ID:nPn32xVP2a Further company coverage: ABT.N
Abbott Laboratories ABT.N:
ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION
ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION
ABBOTT - CARDIOGUIDE HF APP AND DYNAMIC TREATMENT PLAN TO BE AVAILABLE LATER THIS YEAR
Source text: ID:nPn32xVP2a
Further company coverage: ABT.N
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
This New Document Says XRP Is In BNY Mellon’s Global Payments Plan
NASDAQ TRADE HALT CONTINUES <LAWR.O> REASON NOT AVAILABLE AT 03:28 AM
Can AMZN Stock Break Above $280 as Wall Street Turns Bullish?
Trump-Putin Diesel Deal: Will US Crude Oil Fall Below $90?
Crypto prices
More
